Joint Formulary & PAD

Dialysis solutions - Renal dialysis

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Not Specified
Associated Icons :
BNF SPC
R
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Dialysis solutions
Indication :
Renal dialysis
Group Name :
Keywords :
Brand Names Include :
Prismocitrate 10/0, Prismocal B22, Phoxillium
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Dialysis solutions is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Renal dialysis.

  • No records returned.

Committee Recommendations (1)

This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.

See “Formulary Status” to identify where this drug has been agreed for use.